The simulation of IL-10 bolus and TNF-α blockade exemplifies how predictive modeling may anticipate unintended immunological trade-offs, information that is critical given the failure of some clinical anti-cytokine therapies to demonstrate efficacy in stroke trials. This evidence concerns the gene TNF and Stroke.